Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Zash

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
The Lancet. HIV|July 1, 2018
HIV treatment in pregnancyHeather Bailey, Rebecca Zash, Virginia Rasi, et al.
Journal of Virus Eradication|April 24, 2018
Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic reviewAndrew Hill, Polly Clayden, Claire Thorne, et al.
AIDS (London, England)|August 29, 2025
Embracing uncertainty in early safety signals: A lesson from the Tsepamo study results describing neural tube defect risk and the use of Dolutegravir (DTG) in pregnancySean S Brummel, Sonja Swanson, Ellen Caniglia, et al.
Birth Defects Research|March 29, 2021
Limited surface examination to evaluate potential teratogens in a resource-limited settingLewis B Holmes, Hanah Z Nasri, Anne-Therese Hunt, et al.
Annals of Global Health|March 16, 2019
Audit of Early Mortality among Patients Admitted to the General Medical Ward at a District Hospital in BotswanaColleen Kershaw, Margaret Williams, Saikiran Kilaru, et al.
Open Forum Infectious Diseases|September 15, 2020
A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical TrialsKatelyn A Pastick, Melanie R Nicol, Elizabeth Smyth, et al.
The Lancet. HIV|August 7, 2023
Metabolic implications and safety of dolutegravir use in pregnancyValeriya Dontsova, Haneesha Mohan, Camille Blanco, et al.
Pregnancy Hypertension|December 13, 2016
Hypertensive disease in pregnancy in Botswana: Prevalence and impact on perinatal outcomesKatherine M Johnson, Rebecca Zash, Miriam J Haviland, et al.
BMC Medical Research Methodology|October 18, 2021
Are morbidity and mortality estimates from randomized controlled trials externally valid? A comparison of outcomes among infants enrolled into an RCT or a cohort study in BotswanaNeil Thivalapill, Shahin Lockman, Kathleen Powis, et al.
Journal of the International AIDS Society|January 24, 2023
Incident HIV acquisition among pregnant women in Botswana: findings from the Tsepamo birth outcomes surveillance studyAamirah Mussa, Gloria Katuta Mayondi, Modiegi Diseko, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
The Lancet. HIV|July 1, 2018
HIV treatment in pregnancyHeather Bailey, Rebecca Zash, Virginia Rasi, et al.
Journal of Virus Eradication|April 24, 2018
Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic reviewAndrew Hill, Polly Clayden, Claire Thorne, et al.
AIDS (London, England)|August 29, 2025
Embracing uncertainty in early safety signals: A lesson from the Tsepamo study results describing neural tube defect risk and the use of Dolutegravir (DTG) in pregnancySean S Brummel, Sonja Swanson, Ellen Caniglia, et al.
Birth Defects Research|March 29, 2021
Limited surface examination to evaluate potential teratogens in a resource-limited settingLewis B Holmes, Hanah Z Nasri, Anne-Therese Hunt, et al.
Annals of Global Health|March 16, 2019
Audit of Early Mortality among Patients Admitted to the General Medical Ward at a District Hospital in BotswanaColleen Kershaw, Margaret Williams, Saikiran Kilaru, et al.
Open Forum Infectious Diseases|September 15, 2020
A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical TrialsKatelyn A Pastick, Melanie R Nicol, Elizabeth Smyth, et al.
The Lancet. HIV|August 7, 2023
Metabolic implications and safety of dolutegravir use in pregnancyValeriya Dontsova, Haneesha Mohan, Camille Blanco, et al.
Pregnancy Hypertension|December 13, 2016
Hypertensive disease in pregnancy in Botswana: Prevalence and impact on perinatal outcomesKatherine M Johnson, Rebecca Zash, Miriam J Haviland, et al.
BMC Medical Research Methodology|October 18, 2021
Are morbidity and mortality estimates from randomized controlled trials externally valid? A comparison of outcomes among infants enrolled into an RCT or a cohort study in BotswanaNeil Thivalapill, Shahin Lockman, Kathleen Powis, et al.
Journal of the International AIDS Society|January 24, 2023
Incident HIV acquisition among pregnant women in Botswana: findings from the Tsepamo birth outcomes surveillance studyAamirah Mussa, Gloria Katuta Mayondi, Modiegi Diseko, et al.
Pageof 7